TP53 and breast carcinoma: Since BRD7 could increase the protein expression of p53 at post-transcriptional level in breast cancer cells harboring wild-type p53, we then aim to investigate whether BRD7 could stabilize p53 protein to protect it from degradation by ubiquitination.